Robins Lori I, Dixon Seth M, Wilson David K, Kurth Mark J
Department of Chemistry, University of California, One Shields Avenue, Davis, CA 95616, USA.
Bioorg Med Chem. 2006 Dec 1;14(23):7728-35. doi: 10.1016/j.bmc.2006.08.005. Epub 2006 Aug 22.
Aldose reductase (AKR1B1; ALR2; E.C. 1.1.1.21) is an NADPH-dependent carbonyl reductase which has long been associated with complications resulting from the elevated blood glucose often found in diabetics. The development of effective inhibitors has been plagued by lack of specificity which has led to side effects in clinical trials. To address this problem, a library of bead-immobilized compounds was screened against fluorescently labeled aldose reductase in the presence of fluorescently labeled aldehyde reductase, a non-target enzyme, to identify compounds which were aldose reductase specific. Picked beads were decoded via novel bifunctional bead mass spec-based techniques and kinetic analysis of the ten inhibitors which were identified using this protocol yielded IC50 values in the micromolar range. Most importantly, all of these compounds showed a preference for aldose reductase with selectivities as high as approximately 7500-fold. The most potent of these exhibited uncompetitive inhibition versus the carbonyl-containing substrate D/L-glyceraldehyde with a Ki of 1.16 microM.
醛糖还原酶(AKR1B1;ALR2;E.C. 1.1.1.21)是一种依赖烟酰胺腺嘌呤二核苷酸磷酸(NADPH)的羰基还原酶,长期以来一直与糖尿病患者常见的血糖升高所导致的并发症相关。有效抑制剂的开发一直受到缺乏特异性的困扰,这在临床试验中导致了副作用。为了解决这个问题,在存在荧光标记的醛糖还原酶(一种非靶标酶)的情况下,针对荧光标记的醛糖还原酶对一个固定在珠子上的化合物文库进行筛选,以鉴定对醛糖还原酶具有特异性的化合物。通过基于新型双功能珠子质谱的技术对挑选出的珠子进行解码,对使用该方案鉴定出的十种抑制剂进行动力学分析,得到的半数抑制浓度(IC50)值在微摩尔范围内。最重要的是,所有这些化合物都表现出对醛糖还原酶的偏好,选择性高达约7500倍。其中最有效的化合物对含羰基底物D/L-甘油醛表现出非竞争性抑制,抑制常数(Ki)为1.16微摩尔。